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Phenotypic expression of the common p.C282Y/p.C282Y HFE-related hemochromatosis genotype is heterogeneous and depends
on a complex interplay of genetic and non-genetic factors. Haptoglobin has a crucial role in free hemoglobin iron recovery, and
exists as three major types: Hp1-1, Hp2-1 and Hp2-2. Hp2-2 favors endocytosis of hemoglobin iron in monocytes/macrophages,
resulting in partial iron retention and increased intracellular ferritin levels. This situation is generally not expected to severely
aﬀect iron homeostasis, but was found to correlate with elevated serum iron indices in healthy men. Whether the Hp2-2 genotype
acts as a modiﬁer in HFE-related hemochromatosis is unclear. In this study we investigated inﬂuence of Hp2-2 and of potential
confounders on the iron indices of 351 p.C282Y homozygous patients. We conclude that there is a cause-and-eﬀect relationship
between the Hp2-2 genotype and increased iron indices in p.C282Y homozygous patients. The Hp2-2 eﬀect is, however, limited
and only apparent in males.
Copyright © 2009 G´ erald Le Gac et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
H e m o c h r o m a t o s i s( H C ;s y n o n ym o u swi t hh e r e d i t a ryh e m o -
chromatosis) refers to several inherited disorders of iron
metabolism characterized by progressive iron accumulation
in major organs [1–4]. If not recognized and treated, this
progressive iron loading can lead to tissue damage and severe
clinical complications, including cirrhosis, hepatocellular
carcinoma, and cardiomyopathy [5].
The historical and predominant form ofhemochromato-
sis is an adult-onset autosomal recessive condition usually
associated with the HFE p.C282Y/p.C282Y genotype. In
Northern European populations, this genotype is carried by
approximately 1 person in 200 [4]. However, its phenotypic
expressionisheterogeneousandclearlydependsonabalance
between accentuating and reducing factors. The inﬂuence
of gender, age, and lifestyle components, such as alcohol
abuse, has been well documented [2, 6, 7]. Involvement of
modiﬁer genes or epigenetic mechanisms is less obvious, but
is supported by studies in Hfe knockout mice, as well as by
the greater concordance between biological and clinical iron
overload phenotypes within families than between families
[4, 8, 9].
Most iron in the body is directed to erythropoiesis and
is present as heme in hemoglobin (Hb). Hemoglobin iron is
normally recycled after destruction of senescent erythrocytes
by macrophages. Under physiological conditions, however,
up to 10% of Hb molecules escape into the plasma [10].
These free Hb molecules are bound by haptoglobin (Hp),
whichdeliversthemtothehepaticparenchymalcells,Kupﬀer2 Advances in Hematology
cells and other macrophages. In this way, haptoglobin
prevents iron losses through the glomeruli and protects the
kidney against oxidative injury [11].
Haptoglobin is synthesized as a single polypeptide chain,
which is cleaved in the endoplasmic reticulum to an amino-
terminal α-chain and a carboxy-terminal β-chain [12]. The
basic structure of Hp is a homodimer designated Hp1-
1 in which the two Hp molecules are joined by a single
disulﬁde bridge through their respective α-chains. Humans
diﬀer from other species by having two common Hp
alleles (denoted Hp1 and Hp2), which, due to partial gene
duplication, code for either a short or a long α-chain,
and the β-chain. Since the elongated α-chain contains two
cysteine residues that form disulﬁde bridges with two other
α-chains, individuals homozygous for the Hp2 allele show a
multimeric Hp type designated Hp2-2. Hp2-1 refers to the
type (both Hp dimers and multimers) seen in individuals
heterozygous for the two Hp alleles [13].
Hp2-2 has been reported to favor endocytosis of Hb-
Hp complexes by monocytes/macrophages and to produce
partial iron retention [13, 14]. This results in higher intracel-
lular ferritin concentrations, whereas the impact on serum
iron parameters was found to be moderate and to reach
signiﬁcance only in healthy males [14]. In agreement with
thisgender-relatedeﬀect,Hp2-2wasassociatedwithelevated
serum iron and ferritin levels in p.C282Y homozygous male
patients but not in p.C282Y homozygous female patients
[15]. However, this ﬁnding has been challenged by two other
studies [16, 17].
Tolosano et al. have recently reported that Hfe and Hp
compound knockout mice accumulated signiﬁcantly less
hepatic iron than Hfe-null mice, thus demonstrating that
Hp-mediated Hb-iron recovery may contribute to iron load-
ing in HC [18]. Hp2 does not designate a null allele. Rather,
it encodes a protein that could favor free hemoglobin iron
delocalizationintomacrophages.Togaininsightintotherole
of Hp as a modiﬁer gene in HFE-related hemochromatosis,
weinvestigatedtheinﬂuenceoftheHp2-2genotypeinalarge
number of p.C282Y homozygous patients. We hypothesized
that it might be limited and masked by the predominant
eﬀect of gender and other important non-genetic modiﬁers
(age and alcohol abuse).
2.Materials
2.1. Study Patients. Three-hundred and ﬁfty-one patients
were enrolled in the study. At the ﬁrst visit of these patients
to a healthcare center in Brittany (western part of France),
a clinical questionnaire was completed by the specialized
physician. Information contained in this questionnaire was
previously described in detail [6]. It provided information
regarding sociodemographic characteristics of patients, their
age at diagnosis, the circumstances of HC diagnosis, the
biochemical parameters, and the clinical signs associated at
the time of onset.
Basic reasons for diagnosis were presence of the HFE
p.C282Y/p.C282Y genotype and the observation of abnor-
mal iron indices (elevated transferrin saturation with or
withoutelevatedserumferritinconcentration).Itmeansthat
not all patients presented with clinical signs.
The selected patients did not carry additional mutations
onHAMP andHJV,twopreviouslyreportedmodiﬁersofthe
p.C282Y homozygous phenotype [19, 20].
This study complied with French bioethics regulations.
Informed consent of patients was obtained before blood
samples were taken.
2.2. Assessment of the Amount of Iron Removed by Phlebotomy
andofDailyAlcoholConsumption. Allpatientswerefollowed
up in the same healthcarecenter, under regular practices (the
targeted value for serum ferritin was 100μg/L).
Theamountofironremovedbyphlebotomywasassessed
from the volume of blood extracted during depletion
therapy, assuming that 500mL of blood contains 250mg
of elemental iron. A total of 26 patients (17 males and 9
females) had not completed iron depletion therapy when the
study began. This subgroup of patients was excluded from
all statistical analyses of the iron removed by phlebotomy
variable.
Daily alcohol consumption was assessed from a detailed
item included in the clinical questionnaire, which measured
the amount of beer, wine, and liquor consumed, assuming
respective alcohol (ethanol) contents of 4%, 12%, and 20%.
A l c o h o la b u s ew a sd e ﬁ n e da sc o n s u m p t i o no f≥ 60g per day
[21].
2.3. Haptoglobin Genotyping. Haptoglobin polymorphism
was determined using two complementary allele-speciﬁc
PCRs, as fully described by Koch and collaborators [22].
Brieﬂy, a ﬁrst PCR exploits the size diﬀerence due to the two
extra exons of the Hp2 allele. It leads to the ampliﬁcation
of a 1757-bp product from the Hp1 allele and of a 3481-bp
product from the Hp2 allele. Because of the primer binding
sitesandtheir5  to 3  orientations,asecondPCRpermitsthe
ampliﬁcation of a 349-bp product from the Hp2 allele but no
ampliﬁcation from the Hp1 allele. This makes identiﬁcation
of the Hp2-1 heterozygous genotype more reliable as, in the
ﬁrst round of PCR, ampliﬁcation of the Hp1-speciﬁc 1757-
bp product is more eﬃcient and occasionally leads to a very
weak detection of the Hp2-speciﬁc 3481-bp product.
2.4. Statistical Analyses. Statistical analyses were performed
using Epi-Info (version 6.04; Centers for Disease Control
and Prevention, Atlanta, Ga, USA) or SAS (version 9.1; SAS
Institute, Cary, NC) software.
Analysis of variances (ANOVA) and Student’s t-test,
considering either the pooled (equal variance) or the
Satterthwaite (unequal variance) method, were used to
test for between-group diﬀerences in means. Logarithmic
transformation were used for all statistical analyses to ensure
that serum ferrtin and iron removed by phlebotomy were
approximately normally distributed.
The following potential confounders were considered in
multiple linear regression models with either serum ferritin
concentration or amount of iron removed by phlebotomy as
dependent variable: Hp genotypes, gender, age at diagnosisAdvances in Hematology 3
(threedummyvariablesdeﬁnedbythequartileswithquartile
1asreference),andalcoholconsumption(abusersversusnon
abusers). Hp genotype variable was assessed by grouping the
Hp1-1 and Hp2-1 genotypes, and by only considering the
Hp2-2 genotype as potential predictor. This allowed us to
increase the size of the category used as reference. It should
be noted that the Hp genotype variable was initially coded
as two dummy variables (Hp2-1 versus Hp1-1 and Hp2-2
versus Hp1-1), and that by contrast with Hp2-2, Hp2-1 did
not show any association with higher serum ferritin or iron
removed by phlebotomy.
As serum ferritin concentration and iron removed by
phlebotomy were log10 transformed, the regression coeﬃ-
cient β corresponded to a 10β t i m e sc h a n g ei nm e a nY( i . e . ,
serum ferritin or iron removed) per unit increment in the
explanatory variable. In a multiple linear regression model,
the coeﬃcients β are ajusted for the other covariables.”
3. Results
3.1. Hp Genotype Distribution. Hp genotypes among the 351
p.C282Y homozygous were distributed as follows: 46 for
Hp1-1 (13.1%), 179 for Hp2-1 (51.0%), and 126 for Hp2-
2 (35.9%). These genotype frequencies were in accordance
with previous reports in Northern European populations
[15, 17, 23].
3.2. Iron Overload Status Regarding Hp Genotypes
3.2.1. Univariate Analyses. Analysis of variance failed to
reveal any signiﬁcant diﬀerence between the various Hp
groups of p.C282Y homozygous patients, in terms of age
at diagnosis, transferrin saturation, log-transformed serum
ferritin, and log-transformed iron removed by phlebotomy
(Table 1(a)).
These results contrasted with the positive eﬀects of male
sex and alcohol abuse on all the studied iron parameters
(Tables 1(b) and 1(c); Student’s t-tests).
3.2.2. Multivariate Analyses. Multiple linear regression mod-
els were ﬁtted to test inﬂuence of Hp genotypes (Hp2-2
versus Hp1-1 and Hp2-1) on either log-transformed serum
ferritin or log-transformed iron removed by phlebotomy,
after adjustment for gender, age at diagnosis, and alcohol
consumption (Table 2). For both the dependent variables
assessed, higher values were not only seen in male patients
(P<. 0001 and P<. 0001, resp.), patients of greater age at
diagnosis (P<. 0001 and P<. 0001) and patients who drank
at least 60g of alcohol per day (P = .0073 and P = .0096)
but also in patients with the Hp2-2 genotype (P = .0033 and
P = .0024).
Withlog10 transformationofthedependantvariable(i.e.
serum ferritin), the regression coeﬃcient of the “Hp group”
variable was 0.117. It means that average serum ferritin was
100.117 or 1.31 times higher in patients with Hp2-2 genotype
than in patients with Hp1-1 or Hp1-2 genotype, this after
adjustment on other covariables. The model also indicated
that mean serum ferritin concentration appeared 1.57 times
higher in alcohol abusers that in non alcohol abusers.
We did not observed an interaction between gender and
Hp genotype (P = .5959). However, because gender was
conﬁrmed as the major modiﬁer in phenotypic expression
of the p.C282Y homozygous genotype, and because the
eﬀect of the Hp2-2 genotype on serum iron parameters was
previously restricted to the male sex [14, 15], analyses were
performed in men and women, separately.
3.3. Iron Overload Status Regarding Gender and Hp Geno-
types. As only two of 27 heavy alcohol drinkers were females,
patients who drank less than 60g of alcohol per day were
ﬁrstconsidered.Inthiscategory,analysisofvariancerevealed
signiﬁcant diﬀerences in means of log-transformed serum
ferritin and log-transformed iron removed by phlebotomy
between the various Hp groups of males, but not of females
(data not shown). As expected, subsequent pairwise t-tests
ascribed the observed diﬀerences to higher serum ferritin
and higher iron removed by phlebotomy in male carriers of
the Hp2-2 genotype (data not shown).
Linear regression analysis indicated that these obser-
vations remained unchanged after adjustment for age at
diagnosis and daily alcohol consumption (Tables 3(a) and
3(b)).
4. Discussion
Only a small fraction of hemoglobin iron passes through the
haptoglobin recovery pathway. For this reason, it is generally
believed that Hp polymorphism does not severely aﬀect iron
homeostasis, and does not consistently explain the large
phenotypic variability seen in carriers of the common HFE
p.C282Y/p.C282Ygenotype.However,Vlierbergheetal.have
reported a striking association between Hp2-2 and more
pronounced iron overload phenotypes in p.C282Y/p.C282Y
males [15]. In view of this ﬁnding, and also bearing in mind
contradictoryﬁndings[16,17],ourstudyunderlinesthatthe
contribution of the Hp2-2 type is signiﬁcant but limited. It is
only apparent when considering gender and is further found
to be moderate in comparison to age and alcohol abuse (as
evidenced by regression coeﬃcients in Table 2).
Lack of replication between earlier investigations of
the inﬂuence of the Hp2-2 type on phenotypic expression
of the p.C282Y homozygous genotype may have several
explanations. It notably might reﬂect diﬀerences in selection
and size of the sample studied. Here, we enrolled a large
number of expressive p.C282Y homozygous individuals; that
is, individuals who displayed, at least, biological changes
of the disease (increased transferrin saturation levels, with
or without increased serum ferritin concentrations). This
permittedpowerfulstatisticalanalysesandcarefulevaluation
of the relationship between the Hp2-2 genotype and the
severity of iron overload. In this way, our results were
similar to those initially reported by Vlierberghe et al.
from a cohort of 167 p.C282Y homozygous patients [15].
In the overall population of patients, univariate analyses
revealed that all the studied iron parameters were slightly4 Advances in Hematology
Table 1
(a) Sociodemographic and biochemical characteristics of the 351 p.C282Y homozygous patients according to Hp genotype.
Characteristic Hp genotype
Hp1-1 Hp2-1 Hp2-2 P value
Sociodemographic
Number of patients 46 179 126
Gender (Males, Females) 32 M, 14 F 99 M, 80 F 64 M, 62 F
Age at diagnosis (years) 46.5 ± 10.8 47.4 ± 13.8 46.4 ± 13.8 0.7887
Biochemical
Transferrin saturation (%) 76.8 ± 15.1 78.7 ± 14.3 80.0 ± 12.9 0.4009
Serum ferritin (μg/L) 604 [310–1136] 570 [280–1024] 631 [329–1196] 0.3580
Iron removed (g)1 3.6 [1.8–6.1] 3.3 [1.8–5.6] 3.9 [2.0.–6.8] 0.3030
(b) Sociodemographic and biochemical characteristics of the studied 351 p.C282Y homozygous patients according to gender.
Characteristic Gender
Males Females P value
Sociodemographic
Number of patients 195 156
Age at diagnosis (years) 46.5 ± 12.5 47.5 ± 14.5 0.4854
Biochemical
Transferrin saturation (%) 82.0 ± 13.1 75.0 ± 14.0 < 0.0001
Serum ferritin (μg/L) 892 [553–1732] 320 [179–562] < 0.0001
Iron removed (g)1 4.9 [3.4–8.2] 3.2 [2.0–5.8] < 0.0001
(c) Sociodemographic and biochemical characteristics of the studied 351 p.C282Y homozygous patients according to alcohol consumption.
Characteristic Alcohol consumption
≥ 60 g/day < 60 g/day P value
Sociodemographic
Number of patients 27 324
Gender (Males, Females) 25 M, 2 F 170 M, 154 F
Age at diagnosis (years) 48.9 ± 12.5 46.7 ± 13.5 0.4185
Biochemical
Transferrin saturation (%) 88.3 ± 8.0 78.1 ± 14.0 0.0002
Serum ferritin (μg/L) 1256 [658–2315] 562 [283–967] < 0.0001
Iron removed (g)1 6.8 [4.8–9.7] 3.4 [1.8–5.9] < 0.0001
1N = 325 (178 males and 147 females).
Age at diagnosis and transferrin saturation are expressed as mean ± standard deviation.
Serum ferritin concentrations and iron removed by phlebotomy are presented as median and interquartile range.
increased in carriers of the Hp2-2 genotype. Stratiﬁcation
of the population by gender was, however, needed to obtain
signiﬁcant diﬀerences. These diﬀerences were restricted to
the male subgroup, and to markers of body iron excess.
As HFE-related hemochromatosis develops slowly, gen-
der and age are recognized as important modifying factors
[3]. Menstruation and pregnancy, which deplete iron stores,
actastemporaryprotectivefactorsinwomenofreproductive
age, whereas biological changes and subsequent clinical
manifestations of the disease are commonly less marked in
younger people than in older people. In addition, alcohol
intake is known to worsen the hepatic damage produced
by iron overload [21, 24]. We have previously shown
that alcohol abuse (alcohol consumption >60g per day)
results in higher iron parameters, and more frequent clinical
manifestations [6]. To permit a more incisive examination of
whether there is a true cause-and-eﬀect relationship between
the Hp2-2 genotype and increased iron parameters, we ﬁtted
multiple linear regression models withgender,butalso ageat
diagnosis and alcohol abuse as potential confounders. These
models led to the presentation of the Hp2-2 genotype as an
independent factor increasing serum ferritin concentrations
and iron removed by phlebotomy (Table 2). However, the
models also showed that Hp2-2 was the lowest predictor.
Adjusting for the strong eﬀect of sex and age, carriers
of the Hp2-2 genotype were thus less likely than alcohol
abusers to have elevated serum ferritin and iron removed
by phlebotomy. This latter point was veriﬁed in speciﬁc
tests where medians for serum ferritin and iron removed
by phlebotomy were signiﬁcantly higher in alcohol abusers
(who carried the Hp1-1 or Hp1-2 genotype) than in patients
with the Hp2-2 genotype (who declared no excessive alcoholAdvances in Hematology 5
Table 2: Regression coeﬃcients (β) and 95% conﬁdence intervals (CIs) for variables inﬂuencing serum ferritin (µg/L; log10 transformed)
and iron removed by phlebotomy (g; log10 transformed) in p.C282Y homozygous patients.
Variable Serum ferritin1 Iron removed2
10β (95% CI) P value 10β (95% CI) P value
Gender3 0.33 (0.27, 0.39) < 0.0001 0.38 (0.33, 0.45) < 0.0001
Age at diagnosis4
Quartile 2 1.33 (1.05, 1.69) 0.0204 1.27 (1.02, 1.58) 0.0304
Quartile 3 1.77 (1.39, 2.26) < 0.0001 1.48 (1.19, 1.84) 0.0005
Quartile 4 1.88 (1.47, 2.39) < 0.0001 1.63 (1.30, 2.03) < 0.0001
Alcohol consumption5 1.57 (1.13, 2.18) 0.0073 1.53 (1.11, 2.12) 0.0096
Hp group6 1.31 (1.09, 1.57) 0.0033 1.29 (1.09, 1.52) 0.0024
1N = 351 (195 males and 156 females). Adjusted r 2 = 38.3%.
2N = 325 (178 males and 147 females). Adjusted r 2 = 36.1%.
3Male sex was used as the reference category.
4Quartile 1 was used as the reference category.
5Daily alcohol intake < 60 g was used as the reference category.
6Hp1-1 and Hp2-1 genotypes were grouped and used as the reference category.
Table 3
(a) Regression coeﬃcients (β) and 95% conﬁdence intervals (CIs) for variables inﬂuencing serum ferritin (µg/L; log10-transformed) and iron removed by
phlebotomy (g; log10-transformed) in p.C282Y homozygous males patients.
Variable Serum ferritin1 Iron removed2
10β (95% CI) P value 10β (95% CI) P value
Age at diagnosis3
Quartile 2 1.30 (0.99, 1.71) 0.0603 1.29 (0.99, 1.66) 0.0567
Quartile 3 1.87 (1.39, 2.51) < 0.0001 1.39 (1.05, 1.68) 0.0204
Quartile 4 1.59 (1.19, 2.13) 0.0019 1.50 (1.15, 1.96) 0.0032
Alcohol consumption4 1.59 (1.18, 2.16) 0.0027 1.50 (1.11, 2.04) 0.0096
Hp group5 1.40 (1.13, 1.74) 0.0026 1.38 (1.12, 1.69) 0.0022
(b) Regression coeﬃcients (β) and 95% conﬁdence intervals (CIs) for variables inﬂuencing serum ferritin (µg/L; log10-transformed) and iron removed by
phlebotomy (g; log10-transformed) in p.C282Y homozygous females patients.
Variable Serum ferritin1 Iron removed2
10β (95% CI) P value 10β (95% CI) P value
Age at diagnosis3
Quartile 2 1.26 (0.83, 1.89) 0.2723 1.31 (0.90, 1.91) 0.1574
Quartile 3 1.85 (1.23, 2.78) 0.0033 1.58 (1.09, 2.29) 0.0154
Quartile 4 2.38 (1.58, 3.59) <0.0001 1.87 (1.29, 2.71) 0.0012
Alcohol consumption4 1.37 (0.37, 5.01) 0.6351 1.65 (0.53, 5.15) 0.3892
Hp group5 1.20 (0.89, 1.61) 0.2383 1.17 (0.90, 1.53) 0.2457
1N = 195. Adjusted r2 = 16.2%.
2N = 178. Adjusted r2 = 13.5%.
3Quartile 1 was used as the reference category.
4Daily alcohol intake < 60g was used as the reference category.
5Hp1-1 and Hp2-1 genotypes were grouped and used as the reference category.
intake). The observed values were 1256.0μg/L [Q1 = 803.0,
Q3 = 2311.0] versus 599.0μg/L [Q1 = 319.5; Q3 = 975.0]
(P = .0010) and 6.6g [Q1 = 4.8; Q3 = 9.7] versus 3.6g [Q1 =
1.8; Q3 = 6.8] (P = .0055), repectively.
We conclude that, by accentuating the iron burden,
the frequent Hp2-2 genotype could explain some of the
phenotypic heterogeneity seen in p.C282Y homozygous
hemochromatosis patients. However, we support the idea
that this inﬂuence is weak, and that other genetic and
environmental modifying factors should be considered, to
eﬃciently distinguish those homozygous patients at higher
risk of developing morbid complications.
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